Amarin Corporation plc AMRN
Set alert
12.13 USD +0.02 +0.17%
At close · Nov 2
12.13 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
11.86 Day range 12.27
11.25 52-week range 17.31
- YTD
- -13.11%
- 1 year
- -25.54%
- Open
- 12.11
- Prev close
- 12.11
- Mkt cap
- 509.97M
- Vol
- 100.11K
- Avg vol
- 68.64K
- EPS
- -0.80
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.86
- High
- 12.27
- Forward P/E
- -2.17
- Beta
- 1.93
- Short ratio
- 12.75
- Inst. own
- 17.05%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.5324
- 200-d avg
- 0.70385
- 1y target
- 1.00
5Y chart
Events in this range
- Jan 6, 2023Rating: Jefferies · Hold → Buy
- Jul 19, 2023Rating: Northland Capital Markets · Market Perform → Market Perform
- Jul 20, 2023Rating: Goldman Sachs · Sell → Sell
- Oct 25, 2023Downgrade: Jefferies · Buy → Hold
- Feb 29, 2024Earnings: 0; estimate —; surprise —%
- Jun 18, 2024Rating: Cantor Fitzgerald · — → Overweight
- Jun 20, 2024Rating: Cantor Fitzgerald · — → Overweight
- Jul 31, 2024Earnings: 0.01; estimate —; surprise 120%
- Apr 11, 2025Split: 1 for 20
Signals (88)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| RSI: Overbought | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| RSI: Overbought | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Dec 30, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 30, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 2, 2024 | 1 year ago |
| MACD: Buy Signal | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bullish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Apr 1, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 18, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 27, 2023 | 2 years ago |
| SMA: Bearish | Nov 20, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| RSI: Oversold | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Apr 3, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 27, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bearish | Dec 26, 2022 | 3 years ago |
| SMA: Bullish | Dec 12, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 8, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Jun 27, 2022 | 4 years ago |
| RSI: Oversold | Jun 27, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| RSI: Oversold | May 2, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
| SMA: Bearish | Feb 14, 2022 | 4 years ago |
| SMA: Bullish | Jan 31, 2022 | 4 years ago |
Key statistics
- Market cap
- 187.86M
- Enterprise value
- -108.30M
- Trailing P/E
- 0.00
- Forward P/E
- -2.17
- PEG ratio
- 0.00
- Price / sales
- 0.78
- Price / book
- 0.35
- EPS (TTM)
- -0.10
- Beta
- 1.93
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -16.33%
- Revenue (TTM)
- 241.02M
- Revenue growth
- -36.00%
- Free cash flow
- -17.89M
- Total cash
- 305.73M
- Total debt
- 8.21M
- Return on equity
- -7.26%
- Shares outstanding
- 411.34M
- Short % of float
- 4.42%
- 50-day average
- 0.5324
- 200-day average
- 0.70385
Analyst view
Consensus: underperform
Underperform
Price target (mean) 1.00
Ratings (0m) 3 0 buy · 1 hold · 2 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell2
Next earnings
Consensus EPS estimate -0.03.
Financials — quick view
AMRN Revenue — quarterly 62.31M
AMRN Net income — quarterly -48.62M
AMRN EPS — quarterly -0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 31, 2024 | Jun 1, 2024 | — | 0.01 | +0.06 | +120.00% |
| Feb 29, 2024 | Dec 1, 2023 | — | 0.00 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 20, 2024 | Cantor Fitzgerald | reit | — | Overweight |
| Jun 18, 2024 | Cantor Fitzgerald | reit | — | Overweight |
| Oct 25, 2023 | Jefferies | down | Buy | Hold |
| Jul 20, 2023 | Goldman Sachs | main | Sell | Sell |
| Jul 19, 2023 | Northland Capital Markets | main | Market Perform | Market Perform |
| Jan 6, 2023 | Jefferies | up | Hold | Buy |
About Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Ireland
- Website
- amarincorp.com
News
- Amarin's Q3 Earnings Beat Estimates, Revenues Miss Mark
- Amarin Corporation plc (AMRN) Q3 2026 Earnings Call Transcript
- What Amarin (AMRN) Said on Its Q3 Earnings Call
- Amarin Corp Q3 2026 Earnings Call Transcript
- Amarin Corp Q3 Adj. EPS $0.08 Beats $(0.02) Estimate, Sales $39.550M Miss $43.711M Estimate
- Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
- Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM)
- Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
- Head-To-Head Survey: Amarin (NASDAQ:AMRN) and SCYNEXIS (NASDAQ:SCYX)
- Analyzing Amarin (NASDAQ:AMRN) & Elanco Animal Health (NYSE:ELAN)
Your note
Sign in to keep a note on AMRN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERG AARON D. | Chief Executive Officer | Purchase | Aug 1, 2024 | 805,380 |
| HOLT PATRICK | Chief Executive Officer | Purchase | Jan 21, 2024 | 314,426 |
| KETCHUM STEVEN B | Officer | Conversion of Exercise of derivative security | Jul 30, 2024 | 670,840 |
| MIKHAIL KARIM | Chief Executive Officer | Stock Award(Grant) | Feb 20, 2023 | 283,507 |
| REILLY THOMAS CHARLES | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 30, 2024 | 94,305 |
| WOLD OLSEN PER | Director | Conversion of Exercise of derivative security | Jan 9, 2023 | 171,027 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sarissa Capital Management, LP | 25.15% | 24,850,623 | 11.35M | Sep 29, 2024 |
| Kynam Capital Management, LP | 12.57% | 12,414,628 | 5.67M | Sep 29, 2024 |
| Eversept Partners, LP | 3.35% | 3,309,309 | 1.51M | Sep 29, 2024 |
| Morgan Stanley | 2.58% | 2,545,752 | 1.16M | Sep 29, 2024 |
| SCP Investment, LP | 2.53% | 2,500,000 | 1.14M | Sep 29, 2024 |
| Two Sigma Investments, LP | 2.41% | 2,380,016 | 1.09M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR Portfolio Developed World ex-US ETF | 0.25% | 247,507 | 113.04K | Sep 29, 2024 |
| Delaware Group Equity Fds IV-Delaware Healthcare Fund | 0.19% | 190,000 | 86.77K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.15% | 147,010 | 67.14K | Oct 30, 2024 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.14% | 135,261 | 61.77K | Sep 29, 2024 |
| Invesco ETF Tr II-Invesco NASDAQ Future Gen 200 ETF | 0.07% | 70,675 | 32.28K | Oct 30, 2024 |
| Blackstone Alternative Multi-Strategy Fund | 0.04% | 35,535 | 16.23K | Sep 29, 2024 |